Prague-based healthtech startup Upheal has secured $3.25 million in a seed round led by KAYA VC, Credo Ventures, and Inovia Ventures. The funding will support marketing, engineering, further product development, and expand Upheal’s AI capabilities.
- Upheal was co-founded in 2021 by two Slovaks Juraj Chrappa and Martin Horvath as a result of personal experience with mental health challenges. The startup offers an AI-powered mental health platform for clinicians. According to Upheal, it saves time through note-taking and transcribing sessions, secure video calling, and organizing the data into summaries, highlights, and other analytics.
- Upheal helps therapists to streamline their clinical workflows, saving time on administrative tasks like writing progress notes and treatment plans. The company claims it has processed 90,000 sessions in the last 12 months, and saved mental health professionals 21,000 hours.
Whether you’re a solo practitioner or a large clinic, our combination of proprietary and foundational AI models delivers notes and insights with remarkable accuracy and robust compliance. We support everything from in-person sessions, third-party telehealth platforms, to integrations via API,
Martin Horvath, co-founder & CTO, commented.
- The fresh investment is led by a Prague-based Credo Ventures, with participation from KAYA Ventures and Inovia Capital. In total, Upheal raised $4.35 million of funding.
- Several angel investors also joined the round, notably Martin Viecha, VP of Investor Relations at Tesla, and Aakash Desai of Decoder Ventures.
Upheal will use the funding for the expansion of its AI capabilities and improving its platform to allow for fully customizable AI templates, AI-powered progress tracking, group therapy, simplifying the therapist’s workflows, and more. It will also support marketing, engineering, and further product development.
